MAPT and Parkinson disease: α-synuclein, tau, and Aβ42 in CSF, blood, and other bodily fluids have garnered significant attention from researchers as potential molecular biomarkers of Parkinson’s disease (Parnetti et al., 2013, 2014; Hall et al., 2015; Mollenhauer et al., 2017).